According to a new market report published by Lucintel, the future of the fetal bovine serum market looks promising with opportunities in biopharmaceutical, cell culture, and human & animal vaccine production applications. The global fetal bovine serum market is expected to grow with a CAGR of 6% from 2020 to 2025. The major drivers for this market are increasing research activities related to drug discovery and rising biopharmaceutical production.
To download report brochure, please go to https://www.lucintel.com/fetal-bovine-serum-market.aspx and click "download brochure" tab from the menu
Fetal bovine serum is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin, and clotting factors. It contains a large number of nutritional and macromolecular factors essential for cell growth. In this market, biopharmaceutical, cell culture, and human & animal vaccine production are the major applications. Lucintel forecasts that cell culture will remain the largest application segment over the forecast period due to its increasing usage as a supplementary substance during cell culture protocols in order to give cultured cells optimum growth factors, growing awareness of the benefits of cell culture-based vaccines, and rising focus on personalized medicine.
Within this market, biotechnology and pharmaceutical companies will remain the largest end user segment over the forecast period due to increasing research and development activities related to drug discovery and increasing production of vaccines.
North America will remain the largest region over the forecast period due to increasing research and development activities in biotechnology, rising healthcare investments by manufacturers, and presence of major players in the region.
Merck, GE Healthcare, Thermo Fisher Scientific, TCS Biosciences, HiMedia Laboratories, Atlanta Biologicals, PAN-Biotech, Rocky Mountain Biologicals, Bovogen Biologicals, and Tissue Culture Biologicals are among the major suppliers in the global fetal bovine serum market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global fetal bovine serum market by product, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Fetal Bovine Serum Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global fetal bovine serum market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Charcoal Stripped
Chromatographic
Dialyzed FBS (Fetal Bovine Serum)
Exosome Depleted
Stem Cell
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biopharmaceutical
Cell Culture
Human & Animal Vaccine Production
Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Biotechnology & Pharmaceutical Companies
Academic Institutes
Research Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.